Drugs News and Research

RSS

Wellpartner agrees to provide patients access to low-cost medications using 340B Access Solution

Wellpartner, a nationally recognized provider of pharmacy distribution services, today announced an agreement with Community Health Center La Clinica and Custom Prescription Shoppe Pharmacy to provide patients access to low-cost medications using Wellpartner's 340B Access Solution. The agreement will allow patients who qualify to purchase deeply-discounted prescription medications at Community Health Center La Clinica's newly established in-house pharmacy as well as through a network of retail pharmacies in the area.

24 Jun 2010

Parenting style strongly affects teens when it comes to heavy drinking: Study

Parents may be surprised, even disappointed, to find out they don't influence whether their teen tries alcohol. But now for some good news: Parenting style strongly and directly affects teens when it comes to heavy drinking - defined as having five or more drinks in a row - according to a new Brigham Young University study.

24 Jun 2010

New Cancer Research UK figures: Deaths from stomach cancer drop

Deaths from stomach cancer are the lowest since UK records began nearly 40 years ago, according to new Cancer Research UK figures released today (Thursday).

24 Jun 2010

Researchers find way to get beneficial effects of estrogen without increasing woman's risk of cancer

Researchers at UT Southwestern Medical Center have pinpointed a set of biological mechanisms through which estrogen confers its beneficial effects on the cardiovascular system, independent of the hormone's actions on cancer. Their investigation suggests that drugs targeting a specific subpopulation of estrogen receptors found outside the cell nucleus might activate the cardiovascular benefits of estrogen without increasing cancer risk.

24 Jun 2010

Health Diagnostic Laboratory announces new capability to run CYP2C19 genetic test

Health Diagnostic Laboratory, Inc., a leader in disease state management, today announced its new capability to run the CYP2C19 genetic test. HDL, Inc., headquartered in the Virginia Biotechnology Research Park, has added CYP2C19 to its comprehensive panel of tests to help physicians better personalize treatment based on an expanded, total patient profile.

24 Jun 2010

Treatment options for patients with MS

The best one-word description for multiple sclerosis is "unpredictable," according to the June issue of Mayo Clinic Women's HealthSource. MS interferes with the communication between the brain and the rest of the body. Just how that interference plays out in symptoms is different for everyone -- thus, the unpredictable label.

24 Jun 2010

Anthera commences enrollment in pivotal VISTA-16 Phase 3 clinical study of varespladib

Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced patient enrollment has commenced in the Company's pivotal VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome for 16 Weeks) Phase 3 clinical study of varespladib (A-002).

23 Jun 2010

Scientists discover septet of overactive genes that control bodily function

In what is believed to be the largest review of the human genetic code to determine why some people's blood platelets are more likely to clump faster than others, scientists at Johns Hopkins and in Boston have found a septet of overactive genes, which they say likely control that bodily function.

23 Jun 2010

NaturalNano nanotubes improve targeting of circulating tumor cells: Study

NaturalNano, Inc. announced today that Dr. Michael King, a researcher at Cornell University, has published a new study demonstrating how NaturalNano nanotubes can improve targeting of circulating tumor cells (CTC's). These nanotubes, when added to the surface where cancer cells are attracted, enhance the natural rolling mechanism that Dr. King believes will allow them to be exposed to specific drugs or other therapeutic agents, or isolated for diagnostic and research purposes.

23 Jun 2010

Santaris Pharma, miRagen collaborate to develop microRNA-targeted medicines for cardiovascular disease

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies and miRagen Therapeutics, Inc., a biopharmaceutical company focused on developing innovative microRNA-based therapeutics for cardiovascular and muscle disease, announced today that they have formed a strategic alliance to develop microRNA-targeted medicines for the treatment of cardiovascular disease.

23 Jun 2010

EUCODIS Bioscience launches high-performance beta-lactamase

EUCODIS Bioscience, a developer and manufacturer of customized enzymes today announced that it has launched a high-performance beta-lactamase designed to inactivate a broad range of beta-lactam antibiotics. EUCODIS Bioscience is marketing the product under the LacBuster(TM) brand.

23 Jun 2010

Engineering and Physical Sciences Research Council awards £1.2 million to Bilayer Platform project

Scientists at the University of Southampton and Birkbeck College, University of London are developing a platform consisting of an array of artificial cell membranes that will enable more efficient testing of potential new drugs.

23 Jun 2010

Researchers develop experimental approaches, analysis tools to understand phenotypic expression

The Human Genome Project, along with numerous parallel efforts to solve the DNA sequences of hundreds of animal, plant, fungal, and microbe genomes in the last few decades, has produced enormous amounts of genetic data with which researchers are struggling to keep pace.

23 Jun 2010

K-State chemical engineer patents chemical structure to make natural personal care products in lab

A Kansas State University chemical engineer has developed and patented a chemical structure to make all-natural personal care products and purer pharmaceuticals in the laboratory.

23 Jun 2010

Student receives two-year $46,000 fellowship to research on a parasite that causes Chagas' disease

Michelle Oppenheimer of Charlotte, N.C., a Ph.D. student in biochemistry in the College of Agriculture and Life Sciences at Virginia Tech, has received a two-year $46,000 fellowship from the American Heart Association to advance her research on a parasite that causes Chagas' disease, which can lead to swelling and inflammation of the heart.

23 Jun 2010

UCL scientists explain Parkinson's disease patients' ICBs

Scientists at UCL have explained Parkinson's patients' risky behaviour, a rare side effect of standard treatments for the disease. The finding has implications for future medication of patients.

23 Jun 2010

Nymox reports positive new results from NX02-0014 follow-up study of NX-1207 for BPH

Nymox Pharmaceutical Corporation is pleased to report positive new results from the 48-60 month follow-up study of patients treated with NX-1207 in Study NX02-0014. The initial study, completed in the U.S. in 2006, reached statistical significance in Intent-to-Treat Primary Efficacy outcomes at 90 days post-treatment with NX-1207 2.5 mg.

23 Jun 2010

European drugmakers lead in making medicines available to developing world, Index says

European drug companies came out ahead of their U.S. counterparts in making medicines available to people in developing countries, but their lead is beginning to shrink, according to the Access to Medicines Index, released on Monday, Reuters reports (Kelland, 6/21).

23 Jun 2010

Canada and New Zealand charities join international alliance in global fight against bowel cancer

UK charity Beating Bowel Cancer and Bowel Cancer Australia today welcomed the addition of the Colorectal Cancer Association of Canada and Beat Bowel Cancer New Zealand to the bowel cancer international alliance, Bowel Cancer International.

23 Jun 2010

Mass. weighs overhaul's effects; Conn. first state to add adults to Medicaid under new health law

"In most states, the passage of the sprawling federal health care overhaul legislation means the poorest will have a better shot at affording health insurance. But in Massachusetts, the law might have the opposite effect. Senator John. F. Kerry, state leaders, and health care advocates met yesterday to discuss a new report that highlights the major differences between the federal and state health care models. The focus of the event quickly turned to the hurdles of implementation and the need to protect the gains Massachusetts has made since 2006. ... The report reveals that ... some Massachusetts residents might end up facing higher premiums" (Lee, 6/22).

23 Jun 2010

Drugs News and Research

Wellpartner agrees to provide patients access to low-cost medications using 340B Access Solution

Parenting style strongly affects teens when it comes to heavy drinking: Study

New Cancer Research UK figures: Deaths from stomach cancer drop

Researchers find way to get beneficial effects of estrogen without increasing woman's risk of cancer

Health Diagnostic Laboratory announces new capability to run CYP2C19 genetic test

Treatment options for patients with MS

Anthera commences enrollment in pivotal VISTA-16 Phase 3 clinical study of varespladib

Scientists discover septet of overactive genes that control bodily function

NaturalNano nanotubes improve targeting of circulating tumor cells: Study

Santaris Pharma, miRagen collaborate to develop microRNA-targeted medicines for cardiovascular disease

EUCODIS Bioscience launches high-performance beta-lactamase

Engineering and Physical Sciences Research Council awards £1.2 million to Bilayer Platform project

Researchers develop experimental approaches, analysis tools to understand phenotypic expression

K-State chemical engineer patents chemical structure to make natural personal care products in lab

Student receives two-year $46,000 fellowship to research on a parasite that causes Chagas' disease

UCL scientists explain Parkinson's disease patients' ICBs

Nymox reports positive new results from NX02-0014 follow-up study of NX-1207 for BPH

European drugmakers lead in making medicines available to developing world, Index says

Canada and New Zealand charities join international alliance in global fight against bowel cancer

Mass. weighs overhaul's effects; Conn. first state to add adults to Medicaid under new health law

Drug Discovery - Second Edition eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News